These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18444931)
1. C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients. Rother RP; Arp J; Jiang J; Ge W; Faas SJ; Liu W; Gies DR; Jevnikar AM; Garcia B; Wang H Am J Transplant; 2008 Jun; 8(6):1129-42. PubMed ID: 18444931 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation. Wang H; Arp J; Liu W; Faas SJ; Jiang J; Gies DR; Ramcharran S; Garcia B; Zhong R; Rother RP J Immunol; 2007 Oct; 179(7):4451-63. PubMed ID: 17878341 [TBL] [Abstract][Full Text] [Related]
3. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Wang H; Rollins SA; Gao Z; Garcia B; Zhang Z; Xing J; Li L; Kellersmann R; Matis LA; Zhong R Transplantation; 1999 Dec; 68(11):1643-51. PubMed ID: 10609940 [TBL] [Abstract][Full Text] [Related]
4. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine. Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054 [TBL] [Abstract][Full Text] [Related]
5. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48. Yang TY; Sun Y; Langnas AN; Zhao Y Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405 [TBL] [Abstract][Full Text] [Related]
6. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model. Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model. Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500 [TBL] [Abstract][Full Text] [Related]
8. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293 [TBL] [Abstract][Full Text] [Related]
9. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients. Ruiz P; Fuller J; Sanfilippo F Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009 [TBL] [Abstract][Full Text] [Related]
10. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684 [TBL] [Abstract][Full Text] [Related]
12. Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Raedler H; Vieyra MB; Leisman S; Lakhani P; Kwan W; Yang M; Johnson K; Faas SJ; Tamburini P; Heeger PS Am J Transplant; 2011 Jul; 11(7):1397-406. PubMed ID: 21668627 [TBL] [Abstract][Full Text] [Related]
13. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244 [TBL] [Abstract][Full Text] [Related]
14. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
15. Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts. Brown K; Nowocin AK; Meader L; Edwards LA; Smith RA; Wong W Am J Transplant; 2016 Apr; 16(4):1129-38. PubMed ID: 26799449 [TBL] [Abstract][Full Text] [Related]
16. A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy. Guo Z; Zhao D; Sa R; Wang L; Li S; Zhao G; Zhu L; Chen G Front Immunol; 2023; 14():1223567. PubMed ID: 37475867 [TBL] [Abstract][Full Text] [Related]
17. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine. Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208 [TBL] [Abstract][Full Text] [Related]
18. Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates. Chen Song S; Zhong S; Xiang Y; Li JH; Guo H; Wang WY; Xiong YL; Li XC; Chen Shi S; Chen XP; Chen G Am J Transplant; 2011 Oct; 11(10):2057-66. PubMed ID: 21831160 [TBL] [Abstract][Full Text] [Related]
19. Survival, function, morphology and serological aspects of rat renal allografts. Effect of short-term treatment with cyclosporine A, anti-CD4 and anti-interleukin-2 receptor monoclonal antibodies. Steinbrüchel DA; Larsen S; Kristensen T; Starklint H; Koch C; Kemp E APMIS; 1992 Aug; 100(8):682-94. PubMed ID: 1520480 [TBL] [Abstract][Full Text] [Related]
20. Prevention of corneal allograft rejection in a mouse model of high risk recipients. Vítová A; Filipec M; Zajícová A; Krulová M; Holán V Br J Ophthalmol; 2004 Oct; 88(10):1338-42. PubMed ID: 15377562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]